NON HODGKINS LYMPHOMA OF ORAL CAVITY

Authors

  • Dr. Kanupriya Gupta Senior Research Fellow, Faculty of Dental Sciences, IMS, BHU, Varanasi (U.P.)
  • Dr. Jatin Gupta M.D.S, Oral Medicine and Radiology.

Keywords:

lymphoma, oral cavity, dental care, oral manifestations

Abstract

Lymphoma is a malignant disease with two forms: Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). Non-Hodgkin’s lymphoma is diagnosed in extranodal sites in 40% of cases, and the head and neck region is the second most affected, with an incidence of 11–33%, while HL has a very low incidence in extranodal sites (1–4%). Among the intraoral findings, the most frequent are ulcerations, pain, swelling, and tooth mobility, while the extraoral findings included facial asymmetry and cervical, submandibular, and submental lymphadenopathy. The few studies reporting imaging findings, the lesions include hypodense lesions with diffuse boundaries, bone resorptions, and tooth displacements.

References

I. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol

;12:3835–3849

II. Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:519–525

III. Ellis GL. Lymphoid lesions of salivary glands: Malignant and Benign. Medicina oral, patologia oral y cirugia bucal 2007 ;12(7):E479-85

IV. Navarro C,Shibli JA,Ferrari RB,D’Avila S,Sposto MR. Gingival Primary Extranodal Non-Hodgkin's Lymphoma as the First Manifestation of Acquired Immunodeficiency Syndrome. Journal of Periodontology 2008, 79(3):562-6 •

V. Evans LS,Hancock BW.Non Hodgkins lymphoma. Lancet 2003;362139-146.

VI. Seymour JF,Solomon B,Wolf MM, Janusczewicz EH,Wirth A, Prince HM. Primary Large-Cell Non-Hodgkin's Lymphoma of the Testis: A Retrospective Analysis of Patterns of Failure and Prognostic Factors. Clinical lymphoma 2001;2(2):109-15 •

VII. Rosenberg A, Biesma DH, Sie-Go DM • Slootweg PJ. Primary extranodal CD3O-positive T-cell non-Hodgkins lymphoma of the oral mucosa. Report of two cases. International Journal of Oral and Maxillofacial Surgery 1996;25(1):57-9

VIII. Richards A ,Costelloe MA,Eveson JW,Scully C, RooneyN. Oral mucosal non-Hodgkin's lymphoma - A dangerous mimic. Oral Oncology 2000;36(6):556-8

IX. Engel EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:401–404.

X. Mawardi H, Cutler C and Treister N (2009) Medical management update: Non-Hodgkin Lymphoma Oral Surg Oral Med Oral Pathol Oral Radiol Oral J Endod 107(1) 19–33

XI. Dumontet C, Drai J, Bienvenu J, et al. Profiles and prognostic

values of LDH isoenzymes in patients with non-Hodgkin’s

lymphoma. Leukemia 1999;13:811–817.

Additional Files

Published

15-05-2017

How to Cite

Dr. Kanupriya Gupta, & Dr. Jatin Gupta. (2017). NON HODGKINS LYMPHOMA OF ORAL CAVITY. International Education and Research Journal (IERJ), 3(5). Retrieved from http://ierj.in/journal/index.php/ierj/article/view/1001

Similar Articles

You may also start an advanced similarity search for this article.